Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Research Alliance Corp III
13G
RACC · G75226103
|
14.1% |
10/7/2026
Event 9/30/2026
|
|||
| Nantahala Capital Management, LLC | 14.1% | ||||
| Wilmot B. Harkey | 14.1% | ||||
| Daniel Mack | 14.1% | ||||
|
Camping World Holdings, Inc.
13G/A
CWH · 13462K109
|
7.2% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 7.2% | ||||
| Wilmot B. Harkey | 7.2% | ||||
| Daniel Mack | 7.2% | ||||
|
Peloton Interactive, Inc.
13G/A
PTON · 70614W100
|
5.2% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 5.2% | ||||
| Wilmot B. Harkey | 5.2% | ||||
| Daniel Mack | 5.2% | ||||
|
Rallybio Corporation
13G/A
RLYB · 75120L209
|
3.6% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 3.6% | ||||
| Wilmot B. Harkey | 3.6% | ||||
| Daniel Mack | 3.6% | ||||
|
Anteris Technologies Global Corp.
13G/A
AVR · 03675P102
|
4.1% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 4.1% | ||||
| Wilmot B. Harkey | 4.1% | ||||
| Daniel Mack | 4.1% | ||||
|
Immunic, Inc.
13G/A
IMUX · 4525EP200
|
7.5% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 7.5% | ||||
| Wilmot B. Harkey | 7.5% | ||||
| Daniel Mack | 7.5% | ||||
|
Quince Therapeutics, Inc.
13G/A
QNCX · 22053A305
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Grace Therapeutics, Inc.
13G/A
GRCE · 00439U104
|
6.8% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 6.8% | ||||
| Wilmot B. Harkey | 6.8% | ||||
| Daniel Mack | 6.8% | ||||
|
Avalo Therapeutics, Inc.
13G/A
AVTX · 05338F306
|
3.5% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 3.5% | ||||
| Wilmot B. Harkey | 3.5% | ||||
| Daniel Mack | 3.5% | ||||
|
Inhibikase Therapeutics, Inc.
13G/A
IKT · 45719W205
|
4.3% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 4.3% | ||||
| Wilmot B. Harkey | 4.3% | ||||
| Daniel Mack | 4.3% | ||||
|
TELA Bio, Inc.
13G/A
TELA · 872381108
|
12.9% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 12.9% | ||||
| Wilmot B. Harkey | 12.9% | ||||
| Daniel Mack | 12.9% | ||||
|
Kiora Pharmaceuticals, Inc.
13G/A
KPRX · 49721T507
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Fulcrum Therapeutics, Inc.
13G
FULC · 359616109
|
8.2% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 8.2% | ||||
| Wilmot B. Harkey | 8.2% | ||||
| Daniel Mack | 8.2% | ||||
|
Biomx Inc.
13G/A
PHGE · 09090D509
|
7.1% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 7.1% | ||||
| Wilmot B. Harkey | 7.1% | ||||
| Daniel Mack | 7.1% | ||||
|
Unicycive Therapeutics, Inc.
13G/A
UNCY · 90466Y202
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Eloxx Pharmaceuticals, Inc.
13G
ELOX · 29014R301
|
9.9% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 9.9% | ||||
| Wilmot B. Harkey | 9.9% | ||||
| Daniel Mack | 9.9% | ||||
|
Azitra, Inc.
13G
AZTR · 05479L302
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
ADC Therapeutics SA
13G
ADCT · H0036K147
|
9.7% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 9.7% | ||||
| Wilmot B. Harkey | 9.7% | ||||
| Daniel Mack | 9.7% | ||||
|
Assertio Holdings, Inc.
13G/A
ASRT · 04546C304
|
0% |
6/2/2026
Event 5/29/2026
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Abeona Therapeutics Inc.
13G/A
ABEO · 00289Y206
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Herbalife Ltd.
13G/A
HLF · G4412G101
|
6.7% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.7% | ||||
| Wilmot B. Harkey | 6.7% | ||||
| Daniel Mack | 6.7% | ||||
|
InspireMD, Inc.
13G/A
NSPR · 45779A846
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Jack in the Box Inc.
13G
JACK · 466367109
|
8.1% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 8.1% | ||||
| Wilmot B. Harkey | 8.1% | ||||
| Daniel Mack | 8.1% | ||||
|
Edesa Biotech, Inc.
13G/A
EDSA · 27966L306
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Envoy Medical, Inc.
13G
COCH · 29415V109
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Keros Therapeutics, Inc.
13G
KROS · 492327101
|
6.9% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.9% | ||||
| Wilmot B. Harkey | 6.9% | ||||
| Daniel Mack | 6.9% | ||||
|
Eventbrite, Inc.
13G/A
EB · 29975E109
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Opus Genetics, Inc.
13G/A
IRD · 67577R102
|
6.5% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.5% | ||||
| Wilmot B. Harkey | 6.5% | ||||
| Daniel Mack | 6.5% | ||||
|
Noodles & Company
13G/A
NDLS · 65540B303
|
9.5% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 9.5% | ||||
| Wilmot B. Harkey | 9.5% | ||||
| Daniel Mack | 9.5% | ||||
|
Quince Therapeutics, Inc.
13G/A
QNCX · 22053A107
|
7.5% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 7.5% | ||||
| Wilmot B. Harkey | 7.5% | ||||
| Daniel Mack | 7.5% | ||||
|
Fossil Group, Inc.
13G/A
FOSL · 34988V106
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Fox Factory Holding Corp.
13G/A
FOXF · 35138V102
|
3.6% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 3.6% | ||||
| Wilmot B. Harkey | 3.6% | ||||
| Daniel Mack | 3.6% | ||||
|
Fractyl Health, Inc.
13G/A
GUTS · 35168W103
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Surrozen, Inc./DE
13G/A
SRZN · 86889P208
|
2.1% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 2.1% | ||||
| Wilmot B. Harkey | 2.1% | ||||
| Daniel Mack | 2.1% | ||||
|
The Hain Celestial Group, Inc.
13G/A
HAIN · 405217100
|
9.4% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 9.4% | ||||
| Wilmot B. Harkey | 9.4% | ||||
| Daniel Mack | 9.4% | ||||
|
Venu Holding Corporation
13G
VENU · 92333E104
|
6.6% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.6% | ||||
| Wilmot B. Harkey | 6.6% | ||||
| Daniel Mack | 6.6% | ||||
|
Gogo Inc.
13G/A
GOGO · 38046C109
|
6.6% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.6% | ||||
| Wilmot B. Harkey | 6.6% | ||||
| Daniel Mack | 6.6% | ||||
|
Helix Acquisition Corp. III
13G
HLXC · G4444S107
|
8.3% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 8.3% | ||||
| Wilmot B. Harkey | 8.3% | ||||
| Daniel Mack | 8.3% | ||||
|
VYNE Therapeutics Inc.
13G
VYNE · 92941V308
|
6.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.0% | ||||
| Wilmot B. Harkey | 6.0% | ||||
| Daniel Mack | 6.0% | ||||
|
Curis, Inc.
13G
CRIS · 231269309
|
10.0% |
4/24/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Assertio Holdings, Inc.
13G/A
ASRT · 04546C205
|
10.7% |
4/7/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.7% | ||||
| Wilmot B. Harkey | 10.7% | ||||
| Daniel Mack | 10.7% | ||||
|
X4 Pharmaceuticals, Inc
13G/A
XFOR · 98420X202
|
2.8% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 2.8% | ||||
| Wilmot B. Harkey | 2.8% | ||||
| Daniel Mack | 2.8% | ||||
|
Verastem, Inc.
13G/A
VSTM · 92337C203
|
4.7% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 4.7% | ||||
| Wilmot B. Harkey | 4.7% | ||||
| Daniel Mack | 4.7% | ||||
|
Vistagen Therapeutics, Inc.
13G/A
VTGN · 92840H400
|
4.7% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 4.7% | ||||
| Wilmot B. Harkey | 4.7% | ||||
| Daniel Mack | 4.7% | ||||
|
Savara Inc.
13G/A
SVRA · 805111101
|
3.6% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 3.6% | ||||
| Wilmot B. Harkey | 3.6% | ||||
| Daniel Mack | 3.6% | ||||
|
Establishment Labs Holdings Inc.
13G/A
ESTA · G31249108
|
3.5% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 3.4% | ||||
| Wilmot B. Harkey | 3.4% | ||||
| Daniel Mack | 3.5% | ||||
|
Korro Bio, Inc.
13G
KRRO · 500946108
|
6.4% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 6.4% | ||||
| Wilmot B. Harkey | 6.4% | ||||
| Daniel Mack | 6.4% | ||||
|
Elutia Inc.
13G/A
ELUT · 05479K106
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Immunic, Inc.
13G/A
IMUX · 4525EP101
|
8.2% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 8.2% | ||||
| Wilmot B. Harkey | 8.2% | ||||
| Daniel Mack | 8.2% | ||||
|
DarioHealth Corp.
13G/A
DRIO · 23725P308
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
DHI Group, Inc.
13G
DHX · 23331S100
|
5.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 5.0% | ||||
| Wilmot B. Harkey | 5.0% | ||||
| Daniel Mack | 5.0% | ||||
|
Bioventus Inc.
13G/A
BVS · 09075A108
|
9.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 9.0% | ||||
| Wilmot B. Harkey | 9.0% | ||||
| Daniel Mack | 9.0% | ||||
|
Aprea Therapeutics, Inc.
13G/A
APRE · 03836J201
|
4.5% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 4.5% | ||||
| Wilmot B. Harkey | 4.5% | ||||
| Daniel Mack | 4.5% | ||||
|
Anebulo Pharmaceuticals, Inc.
13G/A
ANEB · 034569103
|
8.5% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 8.5% | ||||
| Wilmot B. Harkey | 8.5% | ||||
| Daniel Mack | 8.5% | ||||
|
Apyx Medical Corporation
13G/A
APYX · 03837C106
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Evoke Pharma Inc
13D/A
EVOK · 30049G302
|
0% |
12/19/2025
Event 12/17/2025
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Harkey Wilmot B. | 0% | ||||
| Mack Daniel | 0% | ||||
|
Evolus, Inc.
13G/A
EOLS · 30052C107
|
8.9% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 8.9% | ||||
| Wilmot B. Harkey | 8.9% | ||||
| Daniel Mack | 8.9% | ||||
|
Ehealth, Inc.
13G
EHTH · 28238P109
|
5.8% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 5.8% | ||||
| Wilmot B. Harkey | 5.8% | ||||
| Daniel Mack | 5.8% | ||||
|
enVVeno Medical Corporation
13G/A
NVNO · 29415J106
|
3.5% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 3.5% | ||||
| Wilmot B. Harkey | 3.5% | ||||
| Daniel Mack | 3.5% | ||||
|
Destination XL Group, Inc.
13G
DXLG · 25065K104
|
8.4% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 8.4% | ||||
| Wilmot B. Harkey | 8.4% | ||||
| Daniel Mack | 8.4% | ||||
|
COMPASS Pathways plc
13G/A
CMPS · 20451W101
|
3.6% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 3.6% | ||||
| Wilmot B. Harkey | 3.6% | ||||
| Daniel Mack | 3.6% | ||||
|
Unicycive Therapeutics, Inc.
13G/A
UNCY · 90466Y103
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Theratechnologies Inc.
13G/A
THTX · 88338H704
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Trisalus Life Sciences, Inc.
13G/A
TLSI · 89680M101
|
4.1% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 4.1% | ||||
| Wilmot B. Harkey | 4.1% | ||||
| Daniel Mack | 4.1% | ||||
|
Third Harmonic Bio, Inc.
13G/A
THRD · 88427A107
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Altisource Portfolio Solutions S.A.
13G
ASPS · L0175J104
|
8.4% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 8.4% | ||||
| Wilmot B. Harkey | 8.4% | ||||
| Daniel Mack | 8.4% | ||||
|
1 800 Flowers Com Inc
13G/A
FLWS · 68243Q106
|
9.2% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 9.2% | ||||
| Wilmot B. Harkey | 9.2% | ||||
| Daniel Mack | 9.2% | ||||
|
RAPT Therapeutics, Inc.
13G/A
RAPT · 75382E208
|
3.8% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 3.8% | ||||
| Wilmot B. Harkey | 3.8% | ||||
| Daniel Mack | 3.8% | ||||
|
Nektar Therapeutics
13G/A
NKTR · 640268306
|
2.2% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 2.2% | ||||
| Wilmot B. Harkey | 2.2% | ||||
| Daniel Mack | 2.2% | ||||
|
Eagle Pharmaceuticals, Inc.
13G/A
EGRX · 269796108
|
38.1% |
8/14/2025
Event 6/30/2025
|
|||
| Nantahala Capital Management, LLC | 38.1% | ||||
| Wilmot B. Harkey | 38.1% | ||||
| Daniel Mack | 38.1% | ||||
|
DarioHealth Corp.
13G/A
DRIO · 23725P209
|
10.0% |
8/14/2025
Event 6/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Cellectar Biosciences, Inc.
13G/A
CLRB · 15117F880
|
0.1% |
8/14/2025
Event 6/30/2025
|
|||
| Nantahala Capital Management, LLC | 0.1% | ||||
| Wilmot B. Harkey | 0.1% | ||||
| Daniel Mack | 0.1% | ||||
|
uniQure N.V.
13G/A
QURE · N90064101
|
3.8% |
8/14/2025
Event 6/30/2025
|
|||
| Nantahala Capital Management, LLC | 3.8% | ||||
| Wilmot B. Harkey | 3.8% | ||||
| Daniel Mack | 3.8% | ||||
|
Titan Machinery Inc.
13G/A
TITN · 88830R101
|
4.9% |
8/14/2025
Event 6/30/2025
|
|||
| Nantahala Capital Management, LLC | 4.9% | ||||
| Wilmot B. Harkey | 4.9% | ||||
| Daniel Mack | 4.9% | ||||
|
Soleno Therapeutics Inc
13G/A
SLNO · 834203309
|
2.0% |
8/14/2025
Event 6/30/2025
|
|||
| Nantahala Capital Management, LLC | 2.0% | ||||
| Wilmot B. Harkey | 2.0% | ||||
| Daniel Mack | 2.0% | ||||
|
RMR Group Inc.
13G/A
RMR · 74967R106
|
7.2% |
8/14/2025
Event 6/30/2025
|
|||
| Nantahala Capital Management, LLC | 7.2% | ||||
| Wilmot B. Harkey | 7.2% | ||||
| Daniel Mack | 7.2% | ||||
|
Optinose, Inc.
13G/A
OPTN · 68404V209
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Xtant Medical Holdings, Inc.
13D/A
XTNT · 98420P308
|
49.1% |
8/5/2025
Event 8/1/2025
|
|||
| Nantahala Capital Partners Limited Partnership | 11.8% | ||||
| Nantahala Capital Management, LLC | 49.1% | ||||
| Harkey Wilmot B. | 49.1% | ||||
| Mack Daniel | 49.1% | ||||
|
Aytu Biopharma, Inc
13D/A
AYTU · 054754858
|
14.4% |
6/9/2025
Event 6/6/2025
|
|||
| Nantahala Capital Management, LLC | 14.4% | ||||
| Harkey Wilmot B. | 14.4% | ||||
| Mack Daniel | 14.4% | ||||
|
Gaia, Inc.
13G/A
GAIA · 36269P104
|
4.7% |
5/15/2025
Event 3/31/2025
|
|||
| Nantahala Capital Management, LLC | 4.7% | ||||
| Wilmot B. Harkey | 4.7% | ||||
| Daniel Mack | 4.7% | ||||
|
Senti Biosciences, Inc.
13G/A
SNTI · 81726A209
|
8.1% |
5/15/2025
Event 3/31/2025
|
|||
| Nantahala Capital Management, LLC | 8.1% | ||||
| Wilmot B. Harkey | 8.1% | ||||
| Daniel Mack | 8.1% | ||||
|
BiomX Inc.
13G/A
PHGE · 09090D301
|
10.0% |
5/15/2025
Event 3/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Benitec Biopharma Inc.
13G/A
BNTC · 08205P209
|
4.4% |
5/15/2025
Event 3/31/2025
|
|||
| Nantahala Capital Management, LLC | 4.4% | ||||
| Wilmot B. Harkey | 4.4% | ||||
| Daniel Mack | 4.4% | ||||
|
Talphera, Inc.
13D/A
TLPH · 00444T209
|
11.7% |
4/3/2025
Event 3/31/2025
|
|||
| Nantahala Capital Management, LLC | 11.7% | ||||
| Wilmot B. Harkey | 11.7% | ||||
| Daniel Mack | 11.7% | ||||
|
America's Car-Mart, Inc.
13D/A
CRMT · 03062T105
|
7.8% |
3/12/2025
Event 3/10/2025
|
|||
| Nantahala Capital Management, LLC | 7.8% | ||||
| Wilmot B. Harkey | 7.8% | ||||
| Daniel Mack | 7.8% | ||||
|
Conns, Inc.
13G/A
CONNQ · 208242107
|
5.6% |
2/14/2025
Event 12/31/2024
|
|||
| Nantahala Capital Management, LLC | 5.6% | ||||
| Wilmot B. Harkey | 5.6% | ||||
| Daniel Mack | 5.6% | ||||
|
Cellectar Biosciences, Inc.
13G/A
CLRB · 15117F807
|
5.7% |
2/14/2025
Event 12/31/2024
|
|||
| Nantahala Capital Management, LLC | 5.7% | ||||
| Wilmot B. Harkey | 5.7% | ||||
| Daniel Mack | 5.7% | ||||
|
Blacksky Technology Inc.
13G/A
BKSY · 09263B207
|
4.5% |
2/14/2025
Event 12/31/2024
|
|||
| Nantahala Capital Management, LLC | 4.5% | ||||
| Wilmot B. Harkey | 4.5% | ||||
| Daniel Mack | 4.5% | ||||
|
Zevra Therapeutics, Inc.
13G/A
ZVRA · 488445206
|
4.4% |
2/14/2025
Event 12/31/2024
|
|||
| Nantahala Capital Management, LLC | 4.4% | ||||
| Wilmot B. Harkey | 4.4% | ||||
| Daniel Mack | 4.4% | ||||
|
Rezolute, Inc.
13G/A
RZLT · 76200L309
|
4.9% |
2/14/2025
Event 12/31/2024
|
|||
| Nantahala Capital Management, LLC | 4.9% | ||||
| Wilmot B. Harkey | 4.9% | ||||
| Daniel Mack | 4.9% | ||||
|
One Group Hospitality, Inc.
13G/A
STKS · 88338K103
|
6.8% |
2/14/2025
Event 12/31/2024
|
|||
| Nantahala Capital Management, LLC | 6.8% | ||||
| Wilmot B. Harkey | 6.8% | ||||
| Daniel Mack | 6.8% | ||||
|
IMAX Corporation
13G/A
04524E109
|
2.7% |
2/14/2025
Event 12/31/2024
|
|||
| Nantahala Capital Management, LLC | 2.7% | ||||
| Wilmot B. Harkey | 2.7% | ||||
| Daniel Mack | 2.7% | ||||
|
Evoke Pharma, Inc.
13D/A
EVOK · 30049G203
|
16.0% |
2/3/2025
Event 2/3/2025
|
|||
| Nantahala Capital Management, LLC | 16.0% | ||||
| Wilmot B. Harkey | 16.0% | ||||
| Daniel Mack | 16.0% | ||||
|
Codexis, Inc.
13G/A
CDXS · 192005106
|
4.3% |
11/14/2024
Event 9/30/2024
|
|||
| Nantahala Capital Management, LLC | 4.3% | ||||
| Wilmot B. Harkey | 4.3% | ||||
| Daniel Mack | 4.3% | ||||
|
Viemed Healthcare, Inc.
13G/A
VMD · 92663R105
|
2.9% |
11/14/2024
Event 9/30/2024
|
|||
| Nantahala Capital Management, LLC | 2.9% | ||||
| Wilmot B. Harkey | 2.9% | ||||
| Daniel Mack | 2.9% | ||||
|
Strata Skin Sciences, Inc.
13G/A
SSKN · 86272A305
|
9.7% |
11/14/2024
Event 9/30/2024
|
|||
| Nantahala Capital Management, LLC | 9.7% | ||||
| Wilmot B. Harkey | 9.7% | ||||
| Daniel Mack | 9.7% | ||||
|
RumbleOn, Inc.
13G/A
RDNW · 781386305
|
8.7% |
11/14/2024
Event 9/30/2024
|
|||
| Nantahala Capital Management, LLC | 8.7% | ||||
| Wilmot B. Harkey | 8.7% | ||||
| Daniel Mack | 8.7% | ||||
|
Red Violet, Inc.
13G/A
RDVT · 75704L104
|
3.3% |
11/14/2024
Event 9/30/2024
|
|||
| Nantahala Capital Management, LLC | 3.3% | ||||
| Wilmot B. Harkey | 3.3% | ||||
| Daniel Mack | 3.3% | ||||
|
Optinose, Inc.
13G
OPTN · 68404V100
|
10.0% |
11/14/2024
Event 9/30/2024
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Noodles & Company
13G/A
NDLS · 65540B105
|
9.9% |
11/14/2024
Event 9/30/2024
|
|||
| Nantahala Capital Management, LLC | 9.9% | ||||
| Wilmot B. Harkey | 9.9% | ||||
| Daniel Mack | 9.9% | ||||